Hydrogen Bonding between Tetrahydrocannabinol and Vitamin E Acetate in Unvaped, Aerosolized, and Condensed Aerosol e-Liquids
Author(s) -
Adam Lanzarotta,
Travis M. Falconer,
Rick A. Flurer,
Robert A. Wilson
Publication year - 2020
Publication title -
analytical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.117
H-Index - 332
eISSN - 1520-6882
pISSN - 0003-2700
DOI - 10.1021/acs.analchem.9b05536
Subject(s) - chemistry , aerosolization , aerosol , tetrahydrocannabinol , organic chemistry , dronabinol , chromatography , inhalation , biochemistry , anesthesia , cannabinoid , medicine , receptor
Vitamin E acetate (VEA) has recently been identified as a potential chemical of concern in the investigation of e-cigarette, or vaping, product use associated lung injury (EVALI). According to the Centers for Disease Control and Prevention (CDC), most patients report a history of using tetrahydrocannabinol (THC)-containing e-cigarette or vaping products; approximately 50% of the THC-containing vaping products examined by the Food and Drug Administration (FDA) in this investigation have been found to contain VEA. This letter demonstrates that THC and VEA exist in the unvaped e-liquids, vaped e-liquids, and the aerosol produced from vaporizing the mixture, as a hydrogen bonded THC/VEA complex linked by the THC hydroxyl and VEA carbonyl groups. Additional work should therefore be considered to investigate what happens to this complex in the lungs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom